Niva Bupa Health Insurance Company Ltd (NIVABUPA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Niva Bupa Health Insurance Company Ltd on NSE and BSE, with an AI summary of each filing.
Press Release on unaudited financial results for the quarter and half year ended September 30, 2026
Press Release · 04 Nov 2026, 11:22 pm
Niva Bupa Reports 124% PAT Surge in Q2 FY27 Results Niva Bupa Health Insurance posted a 124% YoY surge in PAT to ₹136 crore for Q2 FY27. Gross Written Premium grew 35% YoY to ₹2,484 crore, driven by a 47% rise in Retail Health GWP to ₹1,876 crore. The company maintained an 11% retail health market share in H1 FY27. Annualised Return on Average Net Worth expanded to 14.7% from 7.8% YoY, while the Combined Ratio improved to 98.8%. Claim Settlement Ratio stood at 95.6%, with direct channel growth leading distribution at 46%.
Amendments to the PIT Policies
Others (Uncategorized) · 04 Nov 2026, 9:16 pm
Niva Bupa Consolidates and Amends Insider Trading and UPSI Disclosure Policies Niva Bupa Health Insurance Company Limited's Board of Directors approved amendments to and consolidated its Code of Practices and Procedures for Fair Disclosure of UPSI and Policy for Inquiry in Case of Leak of UPSI on 4th Nov'26. Formulated under Regulation 8(2) of SEBI PIT Regulations, the updated single policy integrates fair disclosure practices and leak inquiry mechanisms into a unified framework to streamline compliance, mandate Structured Digital Database maintenance for minimum 8 years, and formalize an Inquiry Committee for governance.
Investor Presentation for the Earnings call scheduled today i.e. November 04, 2026.
Investor Presentation · 04 Nov 2026, 9:06 pm
Niva Bupa Reports Strong H1'FY27 PAT Surge and Combined Ratio Improvement Niva Bupa Health Insurance reported a 107% YoY surge in PAT to ₹273.4 crore for H1'FY27, up from ₹132.0 crore in H1'FY26 under Ind AS. Gross Written Premium (with 1/n) expanded 33.4% YoY to ₹4,634.0 crore, driven by a 46.9% jump in Retail Health GWP to ₹3,483.5 crore. Retail health market share widened to 11.0% from 9.9%. Underwriting efficiency improved as the Combined Insurance Service Ratio declined 365 bps YoY to 99.5%, while annualized Return on Average Net Worth reached 14.7%.
Outcome of Board meeting held on November 04, 2026
Outcome · 04 Nov 2026, 8:59 pm
Niva Bupa Health Insurance Company Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 04 Nov 2026, 8:54 pm
Niva Bupa Reports Strong H1'27 Results with PAT More Than Doubling YoY Niva Bupa Health Insurance reported Q2'27 net profit after tax of ₹13,564 lakhs, surging 124.1% YoY from ₹6,052 lakhs in Q2'26, though down 1.6% QoQ. Total insurance revenue rose 27.0% YoY to ₹2,41,227 lakhs. Gross Written Premium expanded 34.8% YoY to ₹2,48,405 lakhs. Combined Operating Ratio improved to 93.20% versus 96.62% in Q2'26, aided by a reduced claims ratio of 63.09%. For H1'27, PAT climbed 107.2% YoY to ₹27,344 lakhs. The solvency ratio stood healthy at 2.03x as of 30th Sep'26.
Allotment of 9,89,450 Equity shares.
Others (Uncategorized) · 01 Nov 2026, 11:55 pm
Niva Bupa Health Insurance Allots 9.89 Lakh Equity Shares Under ESOP Schemes Niva Bupa Health Insurance approved the allotment of 9,89,450 equity shares of face value ₹10 each on 1st Nov'26 upon the exercise of stock options by eligible grantees. The allotment includes 8,68,700 shares under ESOP Scheme 2020 and 1,20,750 shares under ESOP Scheme 2024, ranking pari-passu with existing equity. Consequently, the company's paid-up equity share capital increased to ₹1,850.63 crore, comprising 1,85,06,34,153 equity shares of ₹10 each.
Intimation of Earning Call for the quarter and half year ended September 30, 2026
Intimation · 04 Nov 2026, 5:30 pm
Niva Bupa Health Insurance Schedules Q2FY27 Earnings Conference Call Niva Bupa Health Insurance Company Limited will host an earnings conference call for analysts and investors on 4th Nov'26 at 17:30 IST. Organized by ICICI Securities, the call will discuss the company's financial and business performance for the quarter and half year ended 30th Sep'26 (Q2FY27). Senior management, including MD & CEO Krishnan Ramachandran, Executive Director & Deputy CEO Ankur Kharbanda, Executive Director & CFO Vishwanath Mahendra, and COO Bhabatosh Mishra, will represent the company. Universal access numbers include +91 22 6280 1144 and +91 22 7115 8045.
NIVA BUPA HEALTH INSURANCE COMPANY LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 04 Nov 2026, 5:30 am
Niva Bupa Health Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Unaudited ....
Intimation · 04 Nov 2026, 5:30 am
Niva Bupa Health Insurance Board Meeting Scheduled for 4th Nov'26 Niva Bupa Health Insurance Company Limited has scheduled a meeting of its Board of Directors on 4th Nov'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities remains closed until 6th Nov'26.
To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026
Intimation · 04 Nov 2026, 5:30 am
Cessation of Mr. Roger William John Davis, Non-executive Director of the Company w.e.f. October 17, 2026.
Change in Management · 20 Oct 2026, 4:03 am
Niva Bupa Announces Demise of Non-Executive Director Roger William John Davis Niva Bupa Health Insurance Company announced the sudden demise of Non-Executive Director Mr. Roger William John Davis on 17th Oct'26. Consequently, Mr. Davis also ceased to serve as a Member of the Board's Risk Management Committee effective the same date. The formal intimation of his passing was received by the company on 19th Oct'26.
Intimation of Credit Rating assigned by India Ratings and Research Private Limited.
Others (Uncategorized) · 15 Oct 2026, 10:33 pm
India Ratings Assigns 'IND AAA/Stable' to Niva Bupa's Proposed ₹500 Crore Sub-Debt India Ratings and Research has assigned an 'IND AAA/Stable' rating to Niva Bupa Health Insurance Company Limited's proposed ₹500.00 crore subordinated debt issue on 15th Oct'26. The capital will be raised via listed, rated, unsecured, subordinated, redeemable, non-convertible debentures (NCDs), which are yet to be issued. The top-tier rating reflects strong creditworthiness and capital profile for the proposed borrowing.
Intimation of Call Option Notice
Others (Uncategorized) · 15 Oct 2026, 10:29 pm
Niva Bupa Exercises Call Option on ₹150 Crore Subordinated Debentures Niva Bupa Health Insurance Company issued a call option notice to fully redeem 1,500 unsecured, subordinated, non-convertible debentures (10.70% coupon, ISIN: INE995S08010) aggregating ₹150 crore at par. The record date for redemption is set for 2nd Nov'26, with the principal and accrued interest payout scheduled for 13th Nov'26 (preceding business day to the 15th Nov'26 call option date). The company confirmed its post-redemption solvency ratio will remain above the regulatory threshold of 180%, complying with IRDAI regulations.
Outcome of Debt Raising Committee meeting held on October 09, 2026.
Outcome · 09 Oct 2026, 10:18 pm
Niva Bupa Approves Early Redemption of ₹150 Crore Subordinated NCDs Niva Bupa Health Insurance's Debt Raising Committee has approved the exercise of a call option to redeem 1,500 unsecured, subordinated, listed non-convertible debentures (10.70% Niva Bupa 2031) aggregating ₹150 crore at par. Allotted on 15th Nov'21, the debentures will be redeemed five years from allotment. The company set the record date as 2nd Nov'26, with the principal repayment and accrued interest scheduled for payout on 13th Nov'26, adjusted from the 15th Nov'26 call option date due to non-business days.
Niva Bupa Health Insurance Company Limited has informed the Exchange regarding Outcome of Debt Raising Committee Meeting held on October 09, 2026.
Others (Uncategorized) · 09 Oct 2026, 10:14 pm
NIVA BUPA HEALTH INSURANCE COMPANY LIMITED has informed the Exchange about Board Meeting to be held on 09-Oct-2026 to consider Alteration of date of payment of interest or redemption amount.
Intimation · 05 Oct 2026, 10:35 pm
Niva Bupa Health Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2026 ,inter alia, to consider and approve the exercise ....
Intimation · 05 Oct 2026, 10:33 pm
Niva Bupa to Consider Early Redemption of ₹150 Crore NCDs Niva Bupa Health Insurance Company's Debt Raising Committee will meet on 9th Oct'26 to consider and approve exercising a call option for the redemption at par of 1,500 unsecured, subordinated, listed, rated, redeemable NCDs. The debentures aggregate to ₹150 crore (ISIN: INE995S08010) and were originally issued on 15th Nov'21.
Schedule of Institutional investor meet.
Intimation · 24 Sept 2026, 10:36 pm
Niva Bupa Schedules Urgent Institutional Investor Call Niva Bupa Health Insurance Company announced that its management will host a virtual sell-side and buy-side institutional investor call on 24th Sep'26 at 6:00 PM IST. The company scheduled the meeting on short notice, citing the urgency of the matter, in compliance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
Intimation of Credit Rating assigned by AM Best
Others (Uncategorized) · 18 Sept 2026, 4:19 am
AM Best Assigns Stable 'A-' Ratings to Niva Bupa Health Insurance On 17th Sep'26, AM Best assigned Niva Bupa Health Insurance a Financial Strength Rating of A- (Excellent), a Long-Term Issuer Credit Rating of "a-" (Excellent), and an India National Scale Rating of aaa.IN (Exceptional), all with a stable outlook. The ratings reflect a very strong balance sheet, supported by top-tier risk-adjusted capitalization under BCAR and parental backing from Bupa Group. Operating performance remains adequate, supported by four consecutive years of profitability through FY26, delivering a 10.7% ROE and a 102.0% combined ratio.
Change in Management of the Company w.e.f September 16, 2026.
Change in Management · 16 Sept 2026, 11:02 pm
Niva Bupa Health Insurance Announces Key Senior Management Leadership Changes Niva Bupa Health Insurance Company Limited announced senior management changes effective 16th Sep'26. Mr. Vikas Jain, who served as Chief Investment Officer since Oct'20, transitions into a new role as Chief Transformation Officer. Concurrently, Mr. Karan Bhatia has been appointed as the new Chief Investment Officer and designated as Senior Management Personnel. Bhatia has been with the firm's investment division since Dec'15 and possesses over 18 years of experience across the investment and treasury domains.
General updates - ESG Rating
Others (Uncategorized) · 16 Sept 2026, 5:37 pm
Niva Bupa Assigned '67 Leader' Independent ESG Rating by Niche99 Niva Bupa Health Insurance Company received an independent ESG rating of '67 Leader' for FY25 and FY26 from SEBI-registered provider Niche99 ESG Ratings on 15th Sep'26. The company clarified that it did not formally engage the agency; the assessment was conducted independently utilizing publicly available data for FY25 and FY26.
Allotment of 4,11,000 Equity Shares
Others (Uncategorized) · 27 Aug 2026, 3:44 am
Niva Bupa Allots Equity Shares, Increasing Paid-Up Capital Niva Bupa Health Insurance allotted 4,11,000 equity shares of ₹10 face value on Aug 26, '26, following the exercise of options under its ESOP schemes. This includes 1,92,100 shares from ESOP Scheme 2020 and 2,18,900 from ESOP Scheme 2024. Consequently, the company's paid-up equity share capital has increased to ₹18,49,64,47,030, comprising 1,84,96,44,703 equity shares. The newly allotted shares will rank pari-passu with existing equity shares, resulting in a minor equity dilution for current shareholders.
Intimation of Credit rating assigned/reaffirmed by the ICRA Limited
Others (Uncategorized) · 21 Aug 2026, 2:16 am
Niva Bupa Credit Ratings Affirmed and Assigned by ICRA On 20 Aug'26, ICRA reaffirmed Niva Bupa’s issuer rating at [ICRA]AAA with a Stable outlook. Concurrently, ICRA assigned a new rating of [ICRA]AA+ (Stable) to the company's proposed subordinated debt issuance. This involves raising up to ₹500 crores via listed, rated, unsecured, subordinated, redeemable, non-convertible debentures (NCDs). The fundraising proposal was initially disclosed on 30 Jul'26. The new rating assignment facilitates the company's planned capital raise, strengthening its financial flexibility and supporting future growth initiatives.
Receipt of Order from the IRDAI
Others (Uncategorized) · 20 Aug 2026, 8:57 pm
Niva Bupa Faces IRDAI Action Over Expense of Management Limits IRDAI issued an order on 19 Aug'26 warning Niva Bupa for not complying with Expense of Management (EoM) limits for FY25. Consequently, the company is barred from opening any new place of business for six months. Niva Bupa stated there is no quantifiable financial impact from this order. The company is evaluating the directive but noted it was compliant with EoM regulations for FY26 and Q1 FY27, and remains on track for full compliance for the year ending 31 Mar'27.
Scrutinizer''s Report
Annual General Meeting · 13 Aug 2026, 11:17 pm
Niva Bupa Shareholders Overwhelmingly Approve All AGM Resolutions Niva Bupa announced that all resolutions at its 18th AGM on 12 Aug'26 passed with requisite majority. Shareholders approved the FY26 audited financial statements with 99.99% votes in favour. Key approvals included the re-appointment of directors Vishwanath Mahendra and Ankur Kharbanda, each with 99.88% support. The appointment of Ashwani Bhatia as an Independent Director also passed with 99.88% approval. Revisions to remuneration for key management, including the MD & CEO, were also approved with over 99.99% votes in favour.